Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection

Published:2017-11 Issue: Volume:66 Page:103-110
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Jha Manish K.,Minhajuddin Abu,Gadad Bharathi S.,Greer Tracy L.,Mayes Taryn L.,Trivedi Madhukar H.

Funder

NIMH

UT Southwestern

Hersh Foundation

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference55 articles.

1. Chapter 9 - Pharmacological and Neurotoxicological Actions Mediated By Bupropion and Diethylpropion;Arias,2009

2. Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial;Arnow;Am. J. Psychiatr.,2015

3. Bupropion: a review of its mechanism of antidepressant activity;Ascher;J. Clin. Psychiatr.,1995

4. Inflammatory T Helper 17 Cells Promote Depression-like Behavior in Mice;Beurel;Biol. Psychiatry,2013

5. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice;Brustolim;Int. Immunopharmacol.,2006

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of a synbiotic in the management of adults with Attention-Deficit and Hyperactivity Disorder and/or Borderline Personality Disorder and high levels of irritability: Results from a multicenter, randomized, placebo-controlled, “basket” trial;Brain, Behavior, and Immunity;2024-08

2. Dopamine-driven Increase in IL-1β in Myeloid Cells is Mediated by Differential Dopamine Receptor Expression and Exacerbated by HIV;2024-06-10

3. Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder;Clinical Textbook of Mood Disorders;2024-05-30

4. Immunotherapy for depression: Recent insights and future targets;Pharmacology & Therapeutics;2024-05

5. Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis;iScience;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3